Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology

Ads

You May Also Like

Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors

Basking Ridge, New Jersey, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences Appoints Cynthia ...

BioSig Announces Submission of FDA 510(k) Application for PURE EP System

Santa Monica, CA, March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) announced that ...